CrossrefInfokarte
Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Chronic Kidney Disease in France, Based on the EMPA-KIDNEY Clinical Trial
Clinical Drug Investigation · 2024-11 · 44 (11) · 811-828
DOI: 10.1007/s40261-024-01398-4 ↗Abstract
Kein Abstract verfügbar.
EUVIMED